Once-Weekly Injection
A single, easy-to-use prefilled pen delivers a full week of appetite control—no daily pills or shots.
Same active ingredient as Ozempic® at 87 percent less cost—no insurance required.
Start Free EvaluationSemaglutide is a GLP-1 receptor agonist that mimics a natural hormone your intestines release after you eat. By activating GLP-1 receptors in the brain, it:
The combined effect is steady, sustainable weight loss without the constant battle against cravings.
A single, easy-to-use prefilled pen delivers a full week of appetite control—no daily pills or shots.
Clinically proven to quiet food noise and reduce calorie intake by up to 35 percent without feeling deprived.
STEP trials show patients losing 15–18 percent of baseline weight at 68 weeks when paired with lifestyle coaching.
Every batch is compounded in an FDA-inspected, PCAB-accredited facility following USP <795> and <797> standards.
Board-certified physicians review your history, adjust dosing, and monitor progress every step of the way.
Transparent cash pricing—HSA and FSA cards welcome—so you avoid prior auths, denials, or mark-ups.
Monthly membership
$179
HSA/FSA eligible. Cancel or pause anytime.
Appetite quieting begins; you may feel full sooner. Mild nausea possible as your body adjusts.
Weight loss starts; average 1–2 lb/week. Energy improves as blood sugar stabilizes.
Significant fat reduction visible; clothes fit loser. Dose titration optimizes comfort.
Approach goal weight; provider shifts to maintenance dosing to preserve muscle and metabolism.
Individual results vary. Lifestyle counseling included to maximize long-term success.
It is the same active ingredient found in Ozempic® and Wegovy®, prepared in an FDA-regulated outsourcing facility when commercial doses are on shortage. Purity, potency, and sterility are third-party verified.
Clinically, yes. Both contain semaglutide peptide. Ozempic® is the brand-name product manufactured by Novo Nordisk; ours is compounded in a U.S. pharmacy using United States Pharmacopeia (USP) monograph standards.
$179 per month flat fee. That includes medication, provider evaluation, dosing adjustments, and express cold-ship delivery. No hidden consult or refill fees.
No. We operate outside of insurance to keep pricing transparent and accessible. You may, however, pay with HSA or FSA funds; we provide itemized receipts.
A small, painless injection under the skin once a week, any time of day, with or without food. We ship pens with micro-fine needles and include video training.
Most common are mild nausea, constipation, or diarrhea during the first month. We titrate your dose slowly and provide dietary guidance to minimize discomfort. Serious adverse events are rare and reviewed in detail during consult.
In peer-reviewed studies, participants without diabetes lost 14.9 percent of baseline weight at 68 weeks. Individual results depend on adherence, calorie intake, and activity; our coaching program targets 1–2 lb per week steady loss.
Yes. There is no long-term contract. Pause or cancel from your patient portal or by emailing support@novolene.com before your next refill processes.
Take the 5-minute questionnaire to see if compounded semaglutide is right for you. No obligation; results are private.
Start Free Evaluation